🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The study aims at: 1. Perform a multilayer analysis relying on tight integ...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-02-29
Trial ID
NCT05941234
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The WHEAT International trial is a comparative effectiveness trial explorin...
Status
Recruiting
Location
IWK Health
Start Date
2022-01-28
Trial ID
NCT05213806
Treatments Being Tested
This study serves, in part, to prepare for a future large cohort study. The...
Status
Recruiting
Location
University Hospital Antwerp
Start Date
2025-08-13
Trial ID
NCT06523374
Treatments Being Tested
The goal of this prospective cohort study is to learn about the long-term h...
Status
Enrolling By Invitation
Location
icddrb Dhaka hospital, Nutrition research division
Start Date
2024-07-07
Trial ID
NCT06744179
Multiple myeloma is a cancer of the plasma cells in the bone marrow. The m...
Status
Recruiting
Location
Infirmary Health - Diagnostic & Medical Clinic (DMC)
Start Date
2026-01-14
Trial ID
NCT06980480
Treatments Being Tested
The purpose of this study is to confirm the safety and tolerability of elra...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2021-03-22
Trial ID
NCT04798586
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested